REQUEST A DEMO
Total
USD $0.00
Search more companies

Invermab S A S (Colombia)

Main Activities: Lessors of Real Estate
Full name: Invermab S A S Profile Updated: April 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Invermab S A S is a company based in Colombia, with its head office in Bogota D.C.. It operates in the Lessors of Real Estate sector. It was established on December 26, 2016. 2 (2026) employees currently work for Invermab S A S. From the latest financial highlights, Invermab S A S reported a net sales revenue increase of 38.35% in 2025. A growth of 3.02% was recorded in its total assets. The net profit margin of Invermab S A S decreased by 1.91% in 2025.

Headquarters
Cr 15 No 92 36 Of 402 B
Bogota D.C.; Bogota D.C; Postal Code: 0808

Contact Details: Purchase the Invermab S A S report to view the information.

Basic Information
Total Employees:
Purchase the Invermab S A S report to view the information.
Financial Auditors:
Purchase the Invermab S A S report to view the information.
Incorporation Date:
December 26, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Invermab S A S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
38.35%
Total Operating Revenue
38.35%
Operating Profit
-12.1%
Net Profit/Loss for the Period
30.18%
Total Assets
3.02%
Total Equity
19.39%
Operating Profit Margin
-18.35%
Net Profit Margin
-1.91%
Return on Equity (ROE)
1.54%
Quick Ratio
0.61%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?